Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
Ian Pavord, William W. Busse, Elliot Israel, Stanley J. Szefler, Zhen Chen, Nadia Daizadeh, David J. Lederer, Leda Mannent, Nikhil Amin, Elizabeth Laws, Marcella Ruddy, Paul Rowe, Yamo Deniz, Asif Khan, Yi Zhang
Topics & Concepts
DupilumabMedicineExacerbationAsthmaPlaceboBronchodilatorInternal medicineClinical endpointClinical trialGastroenterologyPathologyAlternative medicineAsthma and respiratory diseasesIL-33, ST2, and ILC PathwaysRespiratory and Cough-Related Research